EFFECT OF BASELINE DISEASE ACTIVITY ON ACHIEVING SUSTAINED LOW DISEASE ACTIVITY IN BARICITINIB PHASE 3 STUDIES

Author(s):
Curtis, J.R.; Kavanaugh, A.; Heijde, D. van der; Muram, D.; Alam, J.; Smolen, J.S.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2017), Vol. 76, p. 1130-1131
hdl
1887/116165
doi
10.1136/annrheumdis-2017-eular.1340